Gastric Ulcer Perforation Associated with the Use of Injectable Ketorolac
- 1 January 1993
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 27 (1) , 42-43
- https://doi.org/10.1177/106002809302700111
Abstract
OBJECTIVE: To report a case of a perforated gastric ulcer associated with the use of injectable ketorolac tromethamine. DATA SYNTHESIS: A 77-year-old woman with no previous history of peptic ulcer disease developed a perforated gastric ulcer after four days of treatment with ketorolac. To date, six other cases of gastrointestinal (GI) perforation associated with the use of ketorolac have been reported to the manufacturer. CONCLUSIONS: Although ketorolac is an effective analgesic, it is a nonsteroidal antiinflammatory agent and thus has the propensity for causing GI ulceration. Caution should be used when administering this drug and patients should be monitored for GI adverse effects.Keywords
This publication has 7 references indexed in Scilit:
- Pathogenesis of Peptic Ulcer and Implications for TherapyNew England Journal of Medicine, 1990
- KetorolacDrugs, 1990
- Stress Ulcers: Current Understanding of Pathogenesis and ProphylaxisDrug Intelligence & Clinical Pharmacy, 1988
- Side‐effects of non‐steroidal anti‐inflammatory drugsThe Medical Journal of Australia, 1988
- Nonsteroidal Anti-inflammatory Drug GastropathyArchives of internal medicine (1960), 1987
- Peptic Ulcer Perforation Associated With Steroid UseArchives of Surgery, 1987